Author:
Kabanov Alexander V.,Okano Teruo
Reference159 articles.
1. Langer, R., 1998, Drug delivery and targeting. Nature 392:5–10.
2. Northfelt, D. W., B. J. Dezube, J. A. Thommes, B. J. Miller, M. A. Fischl, A. FriedmanKien, L. D. Kaplan, C. Du Mond, R. D. Mamelok and D. H. Henry, 1998, Pegylatedliposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi’s sarcoma: results of a randomized phase III clinical trial. J. Clin. Oncol. 16:2445–2451.
3. Rosenblum, M. G. and G. N. Hortobagyi, 1986, Pharmacokinetics and tissue disposition of the biological response modifier BAY i 7433 (copovithane) in patients with cancer. Cancer Chemother. Pharmacol. 18:247–251.
4. Duncan, R., S. Gac-Breton, R. Keane, R. Musila, Y. N. Sat, R. Satchi and F. Searle, 2001, Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic. J. Control. Release 74:135–146.
5. Kabanov, A. V. and V. Alakhov, 2002, Pluronic block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers. Cr Rev Ther Dr Targ 19:1–73.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献